|
|
The application value of home atomization inhaled glucocorticoids in the treatment of pediatric respiratory diseases |
MEI Wen-jing ZOU Li FANG Xing HE Ying-hui ZENG Xue-fei |
Department of Pediatrics,Central People′s Hospital of Huizhou City,Guangdong Province,Huizhou 516000,China |
|
|
Abstract Objective To analyze the application value of home atomization inhaled glucocorticoids in the treatment of pediatric respiratory diseases.Methods Slected 90 cases of pediatric respiratory disease patient in our hospital from June 2015 to June 2017,and divided into routine group(45 cases)and experimental group(45 cases)randomly according to computer machine selection,the control group was received routine treatment,the experimental group was received the treatment of home atomization inhaled glucocorticoids.The improvement of clinical symptoms in the two groups was observed,and the family satisfaction and the total effective rate of treatment were analyzed and compared.Results The total effective rate of the treatment in the experimental group was 95.56% (43/45),the total effective rate of the treatment in routine group was 84.44%(38/45),the effect of experimental group was significantly higher than that the routine group,comparison between groups with statistical significance(P<0.05).The experimental group both in the wheezing disappearance time,the chest symptoms disappearing time or breathing difficulties disappear time were shorter than that of the control group,comparison between groups with statistical significance(P<0.05).The total satisfaction degree of the children in the experimental group was 95.56%,which was significantly higher than that of the control group (82.22%),and the differences were statistically significant(P<0.05).Conclusion The use of home atomization inhaled glucocorticoids treatment in pediatric respiratory system disease can significantly improve the treatment rate of children,reduce and relieve the clinical symptoms of children,improve the overall treatment effect,it is worth promoting in clinical use.
|
|
|
|
|
[1] |
郝敏,林江涛.糖皮质激素抵抗性支气管哮喘诊治进展[J].中华结核和呼吸杂志,2014,37(4):296-298.
|
[2] |
裴娇茹,方丽,蒋思琼.小儿哮喘糖皮质激素雾化吸入治疗的家庭管理进展[J].上海护理,2017,17(4):75-78.
|
[3] |
李慧萍.家庭雾化吸入糖皮质激素治疗儿童呼吸系统疾病效果分析[J].实用中西医结合临床,2017,17(2):44-45.
|
[4] |
谌洁怡,陈爱欢,孙丽红.喷射式雾化器雾化吸入糖皮质激素治疗儿童哮喘的临床观察[J].现代医院,2010,10(9):25-27.
|
[5] |
殷勇.家庭雾化吸入治疗注意事项[J].中国实用儿科杂志,2016,31(12):901-903.
|
[6] |
余微微.雾化吸入疗法在儿科呼吸系统疾病中的护理研究[J].当代医学,2016,22(35):105-106.
|
[7] |
张文须,冯选鹏,赵治国.不同剂量糖皮质激素在咳嗽变异性哮喘中的疗效观察[J].中国现代药物应用,2014,8(2):136-137.
|
[8] |
章昌敏.家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用[J].河南医学研究,2016,25(6):1126-1127.
|
[9] |
姜洪娟,张玄,迟翔宇,等.糖皮质激素吸入治疗对支气管哮喘患者血清蛋白质组的影响[J].中华结核和呼吸杂志,2014,37(4):274-278.
|
[10] |
王爱琼,萨日娜,董娜,等.家庭雾化吸入治疗反复喘息患儿疗效观察[J].临床肺科杂志,2015,20(9):1694-1696.
|
[11] |
刘巍,王晓兵,宋志军.糖皮质激素序贯应用在COPD急性发作期的应用效果研究[J].河北医药,2015,37(19):2947-2949.
|
[12] |
张琴.家庭雾化吸入治疗儿童哮喘的病例对照观察[J].医学理论与实践,2015,28(8):1036-1037.
|
[13] |
吴振波,周芳,林如仲.布地奈德每天持续和间歇性雾化吸入预防儿童哮喘发作的疗效比较[J].当代医学,2015,21(8):137-138.
|
[14] |
殷勇,尚云晓.家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用[J].临床儿科杂志,2014,32(6):504-511.
|
[15] |
薛岳珍,郭建军.噻托溴铵联合糖皮质激素治疗夜间哮喘[J].中国冶金工业医学杂志,2014,31(4):455.
|
|
|
|